Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
-
Field
-
We are offering a PhD fellowship in Avian Influenza Modelling at the Department of Veterinary and Animal Sciences, University of Copenhagen commencing 1 July 2024 or as soon as possible hereafter
-
from Aarhus University and University of Copenhagen, as well as international partners. Field experiments, digital technologies -- including modelling and remote sensing, as well as interactions with
-
, Crafoord and BECC. The PhD candidate will be supervised by Dr. Wenxin Zhang together a team of researchers working with field measurements and ecosystem modelling at Lund University, University of Copenhagen
-
with the University of Copenhagen. Disseminating your research findings in highly ranked peer-reviewed journals and international conference proceedings. Strengthening our international collaboration
-
faculties at NTNU, University of Oslo / Oslo University Hospital and University of Copenhagen and cover competences from basic molecular microbiology, chemical synthesis and structural biology/modelling
-
modelling at Lund University, University of Copenhagen, and Universe of Gothenburg. Research outcomes of the project will contribute to two Strategic Research Areas (BECC, Biodiversity and Ecosystem services
-
Hospital and University of Copenhagen and cover competences from basic molecular microbiology, chemical synthesis and structural biology/modelling, bioinformatics, cell biology and immunology/infectious
-
services. Conduct system demonstrations in real-world neural network applications such as natural language processing tasks with our collaborators in the University of Copenhagen. Disseminating your research
-
with SODAS at the University of Copenhagen. PhD scholarship in Linearized floating wind farm modelling - DTU Wind Denmark Posted on 04/29/2024 Are you a curious, self-driven individual with a strong
-
), The Novo Nordisk Foundation Center for Stem Cell Medicine (renew) at University of Copenhagen, and Bioneer A/S that aims at developing new in vitro disease models and cell therapies using human induced